
Episode #196: Want to Start Retatrutide? What You Need to Know Beforehand
In this episode of Conquer Your Weight, Dr. Sarah Stombaugh, board-certified obesity medicine physician, explains when retatrutide may become FDA-approved and what we know about its expected timeline.
Retatrutide is an investigational weight loss medication developed by Eli Lilly that targets GLP-1, GIP, and glucagon receptors. The company has announced plans to submit an application to the FDA in the first quarter of 2027, but retatrutide has not yet been approved, and there is no confirmed FDA approval date. Dr. Stombaugh explains what this means for people interested in this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.